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The integration of salivary biomeasures in biobehavioral, psychophysiological, and clinical research has greatly
expanded our ability to study the biopsychosocial processes underlying health. Much of this research, however,
has failed to adequately assess and adjust for the impact of oral immune activity on salivary biomeasure concentrations and associations with serum levels. Aiming to improve the validity and reliability of salivary biomeasure data, we examine salivary total Immunoglobulin G (IgG) as a potential surrogate marker of oral
inﬂammation and immune activity. During a single study visit in Baltimore, Maryland, healthy young adult
participants provided matched blood and saliva samples (N¼99; age 18–37 years, 42% female) and completed an
oral health questionnaire. Biospecimens were assayed for total IgG and immune markers related to inﬂammation
(cytokines), blood in saliva (transferrin), and tissue remodeling (matrix metalloproteinase-8). Total IgG (μg/mL)
concentrations were higher in serum than saliva. Salivary total IgG was associated with some self-reported oral
health measures, and strongly positively associated with all salivary immune markers. Controlling for salivary
total IgG may be a feasible, affordable approach to adjusting salivary biomeasure ﬁndings for the inﬂuence of the
oral immune environment when it is not possible or practical to obtain clinical oral health data.

1. Introduction

oral ﬂuids (World Health Organization, 2013; U.S. Department of Health
and Human Services, 2000). Along with inﬂammation-related changes in
serum analyte levels in saliva, oral immune activity may directly affect
immune and immunosensitive analyte concentrations (e.g., C-reactive
protein, cytokines). Furthermore, bacterial load and proﬁles are likely
important factors in both oral disease (Taba et al., 2005) and salivary
biomeasure concentrations (e.g., testosterone (Whembolua et al., 2006)).
In addition to biologic effects, there are sociodemographic and
environmental factors related to oral immunity that may confound associations between salivary biomeasures and systemic and mental health.
As with other health conditions, there are racial/ethnic and socioeconomic disparities in the prevalence of poor oral health in the US (Eke
et al., 2018; U.S. Department of Health and Human Services, 2000).
There is also substantial covariation between oral and systemic health
conditions, health behaviors, and rates of access to and utilization of care

The integration of salivary biomeasures in interdisciplinary research
has greatly expanded our ability to examine neuroendocrine, immune,
gonadal, and metabolic function using ecologically-valid and minimallyinvasive measures. The vast majority of studies using salivary analytes as
indices of systemic function, however, have overlooked the potential
confounding effects of oral immune activity on salivary analyte variability and associations with physical and mental health conditions. With
rates of periodontitis over 40% in the US (Eke et al., 2018), oral
inﬂammation is likely a signiﬁcant, yet unmeasured, confound in salivary
biomarker research.
At a biologic level, oral immune activity may directly alter analyte
concentrations in saliva. Early signs of poor oral health include oral
inﬂammation and increased leakage of serum and blood constituents into
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(Mustapha et al., 2007; Lutﬁyya et al., 2019). Thus, the potential confounding effects of oral immune activity in salivary bioscience health
research extend beyond simple biologic factors to include a complex set
of sociodemographic and environmental factors related to both systemic
and oral health.
Controlling for oral health and immunity presents several challenges
for salivary bioscientists. Clinical oral health assessments are often not
feasible. Ideally, investigators could use either a self-report assessment or
low-cost biomarker to control for oral immunity. Anecdotal accounts
from dental clinicians suggest that self-reported blood in saliva after oral
hygiene practices (e.g., brushing, ﬂossing) is a key symptom of poor oral
health. Our work hints that salivary transferrin indexes blood in oral ﬂuid
(Kivlighan et al., 2004), and the oral biology literature suggests proinﬂammatory
cytokines
and
neutrophil
collagenase
(matrix
metalloproteinase-8; MMP-8) may be indices of oral inﬂammation and
connective tissue destruction (Taba et al., 2005; Sorsa et al., 2004; Salminen et al., 2014; Costa et al., 2010; Ghallab, 2018; Nibali et al., 2012;
Gursoy et al., 2009; Noack et al., 2017; Sugiyama et al., 2002; Gornowicz
et al., 2012). Although more precise than self-report, including multiple
oral immune biomeasures as covariates in salivary biomarker studies is
likely impractical and cost prohibitive.
We explore the utility of salivary total Immunoglobulin G (IgG) as a
standalone surrogate marker of oral immune activity. IgG is the most
common antibody in circulation, and, while there is some local production in the oral compartment, most salivary IgG is serum-derived
(Brandtzaeg, 2013). IgG protects against infection from pathogens such
as viruses, toxins, and bacteria (Doan et al., 2008), and total IgG in saliva
may be an indicator of periodontal disease (Taubman and Smith, 1993;
Mahanonda et al., 2016; Ebersole, 2003; Kilian et al., 1989). As a primarily serum-derived antibody, salivary total IgG may be uniquely suited
to serve as an index of oral inﬂammation and injury as well as pathogen
load. Measuring salivary total IgG is also relatively inexpensive and requires very little sample volume.
Using matched blood and saliva samples from healthy adults, we
examine whether variation in salivary total IgG concentrations is unique
to the oral compartment and demonstrates associations with other biologic indices of the oral immune environment, including markers of
blood (transferrin), tissue destruction (MMP-8), and proinﬂammatory
cytokine activity (interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factoralpha (TNFα)). We also examine relations between salivary total IgG
and self-reported measures of oral health, hygiene, and access to care.
We expected to conﬁrm higher levels of total IgG in serum than in
saliva, and higher levels of salivary total IgG when blood levels in saliva
are also high (Schwartz and Granger, 2004). We anticipated total IgG
concentrations in saliva are unrelated to serum levels (Challacombe et al.,
1995), positively associated with other oral immune markers, and related
to self-reported oral health measures.

Table 1
Participant characteristics and self-reported oral health and hygiene.
Characteristic

N (%)a

Female
Age (years)
Body mass index category
Underweight
Healthy weight
Overweight
Obese
Frequency of ﬂossing (times/week)
Frequency of brushing (times/day)
Bleeding gums after daily oral hygiene
Access to oral health care
Poor
Fair
Good
Very good
Excellent
Oral health problems

42 (42%)
23.76 (4.57; 18–37)
4 (4%)
60 (60%)
25 (25%)
5 (5%)
2.07 (2.29; 0–7)
1.98 (0.36; 1–3)
27 (27%)
2 (2%)
4 (4%)
21 (21%)
23 (23%)
45 (45%)
9 (9%)

a
For continuous variables (age, ﬂossing and brushing frequency), the
mean(standard deviation; and range) are shown.

care, and provided a blood and saliva sample. Participants provided
written informed consent and were compensated $50. The university’s
Institutional Review Board approved all study procedures.
2.3. Blood and saliva collection
Blood was drawn by venipuncture, and additional blood was drawn
for serum isolation. Serum was mixed well by inversion and allowed to
clot at room temperature (RT) for 30 min (no longer than 2 hours).
Unstimulated whole saliva was collected via passive drool. Serum and
saliva were aliquoted and stored at 80 ̊C.
2.4. Determination of biomeasures
Total IgG. Brieﬂy, 0.1 mL of sample was added to each well of a 96well plate pre-coated with goat anti-human IgG. Plates were incubated
for 2 h at RT while mixed continuously at 500 rpm. Following incubation,
plates were washed with 1X Wash Buffer and a HRP-linked secondary
antibody was added to each well and incubated for 1 hour at RT while
mixed continuously at 500 rpm. Plates were then washed, treated with
tetramethylbenzidine, and incubated in the dark for 30 min without
shaking. A standard plate reader determined optical density at 450 nm.
Saliva was plated at a 1:1250 and serum was plated at a 1:500,000
dilution. Linearity on dilution and linearity on spike recovery for IgG was
consistent with criterion outlined by Chard (1990). The calibration curve
range was 0.78–50 ng/mL. Samples were assayed in duplicate, and saliva
and serum samples were plated separately. The average inter- and
intra-assay coefﬁcients of variation (CVs) were <6% and <15%,
respectively.
Salivary Total Protein. Given reported associations between salivary
IgG and ﬂow rate (Brandtzaeg, 2013; Nieuw Amerongen et al., 2007),
salivary total protein was measured as an indirect indicator of salivary
ﬂow rate. Total protein was determined using a commercial assay kit
(Pierce™ BCA Catalog #23225, ThermoScientiﬁc) following manufacturer procedures. The test range of sensitivity was 20–2000 μg/mL.
Salivary Transferrin. Blood leakage into saliva, indexed by salivary
transferrin (Schwartz and Granger, 2004), was assayed using a
commercially-available kit (Salimetrics, State College, PA; Catalog
#1–1302) (Kivlighan et al., 2004). The test range of sensitivity was
0.08–6.6 mg/dL, and the inter- and intra-assay CVs were 4.7% and 2.9%,
respectively.
Matrix Metalloproteinase-8. Tissue destruction and remodeling in the
oral compartment, indexed by salivary MMP-8 (Sorsa et al., 2004), was
measured using a commercially-available kit (DuoSet ELISA, R&D Systems, Catalog #DY908) following manufacturer guidelines. The test

2. Material and methods
The data used in this study were examined previously (e.g., Riis et al.,
2017). The study sample, design, and protocols are the same as previously described (see Riis et al., 2017 for details).
2.1. Participants
The sample (N ¼ 99; 42% female) was drawn from a single-visit
research study of healthy young adults (Table 1) conducted in Baltimore, Maryland in 2012–2013. Study protocols excluded participants
reporting medication use (excluding oral contraceptives), acute/chronic
illness, open wounds/sores in their mouth, and recent oral surgery.
2.2. Procedures
During a 45-minute visit, participants completed a demographic
survey, reported on their oral health, hygiene, and access to oral health
2
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examined. Analyses were conducted using Stata SE-15.

range of sensitivity was 62.5–4000 pg/mL, and the inter- and intra-assay
CVs were 5.2% and 3.7%, respectively.
Serum MMP-8 was measured using a development kit (DuoSet ELISA,
R&D Systems, Catalog #DY908) following manufacturer guidelines and
at a 1:25 dilution.
Cytokines. Oral inﬂammation was measured using salivary concentrations of four proinﬂammatory cytokines associated with oral health
(IL-1β, IL-6, IL-8, and TNFα) (Salminen et al., 2014; Costa et al., 2010;
Ghallab, 2018; Nibali et al., 2012; Gursoy et al., 2009; Sugiyama et al.,
2002; Gornowicz et al., 2012). Serum concentrations of these cytokines
were also examined to assess systemic inﬂammation. Cytokines were
measured as part of 9-plex electrochemiluminescence immunoassays
following manufacturer protocols (Meso Scale Discovery, Gaithersburg,
MD; #R51BB) (Riis et al., 2014). Cytokine lower limits of detection were
0.20 pg/mL. Intra-assay CVs were 5.0% and inter-assay CVs were
<7.5%.
We constructed an oral inﬂammation composite score using a principal components analysis of the four salivary cytokines. Results supported one underlying component explaining 76% of the variance in
salivary cytokine concentrations (standardized component loadings ¼
.83-.92).

3. Results
3.1. Preliminary analyses and descriptives
Log-transforming analyte concentration data improved the normality
of data distributions; transformed analyte data skew ranged from 0.63
to 2.66 and kurtosis ranged from 2.68 to 12.29 with only IL-8 and TNFα
in serum exhibiting a kurtosis>6 after transformation. Preliminary analyses found all salivary analytes were positively associated with total
protein concentration in saliva (rs(92–98)¼.35-0.59, ps < .01). Therefore, all subsequent analyses examining salivary analytes controlled for
total protein. Preliminary analyses also supported our conceptualization
of salivary MMP-8, IL-1β, IL-6, IL-8, and TNFα as oral immune indices, as
no signiﬁcant serum-saliva correlations were found for these analytes.
Participant characteristics and a summary of responses to self-report
oral health questions are shown in Table 1. Descriptive statistics for analyte data are shown in Table 2.
3.1.1. Total IgG in serum and saliva
Total IgG concentrations were higher in serum than saliva (Table 2;
t(93) ¼ 69.72, p < .001), and serum total IgG levels were not signiﬁcantly
correlated with salivary levels (partial correlation controlling for salivary
total protein: r ¼ 0.09, p ¼ .39). Salivary total IgG concentrations were
higher among participants with considerable blood in their saliva (salivary transferrin0.5 mg/dL: M(SD) ¼ 27.56 μg/mL (19.25); transferrin<0.5 mg/dL: (M(SD) ¼ 7.28 μg/ml (4.26), t(97) ¼ -9.12, p < .001).
However, serum and salivary total IgG were not signiﬁcantly correlated
among participants above or below the 0.5 mg/dL transferrin threshold.

2.5. Self-reported oral health measures
Participants reported their frequency of ﬂossing and brushing their
teeth; if their saliva had a red/pinkish color when they brushed their
teeth (yes/no); their level of access to oral health care (Likert-type scale;
excellent (5)-poor(1)); and if they had oral health problems (e.g., open
cuts/sores, untreated cavities; yes/no). Brushing frequency was dichotomized at twice a day (American Dental Association, 2013). A composite
score representing self-reported oral health was constructed by summing
responses to these ﬁve questions (each rescored/rescaled to a 0–1 scale).
This composite score ranged from 1.25 to 5 (M(SD) ¼ 3.62(0.83)) with
higher scores representing better self-reported oral health.

3.2. Total IgG and immune markers
Salivary total IgG was positively associated with all other oral immune markers (Table 3). All these relations, except those between salivary total IgG and salivary MMP-8 and the oral inﬂammation composite
score, had signiﬁcant non-linear slope estimates with steeper positive
slopes at lower concentrations and a plateauing of slopes at higher concentrations (linear and quadratic slope estimates for salivary total IgG
and: transferrin-t(98) ¼ 8.89, p < .001, t(98) ¼ -5.12, p < .001; IL-1βt(98) ¼ 6.05, p < .001, t(98) ¼ -3.56, p < .01; IL-6- t(98) ¼ 6.57, p < .001,
t(98) ¼ -5.31, p < .001; IL8-t(98) ¼ 5.28, p < .001, t(98) ¼ -2.94, p < .01;
TNFα-t(98) ¼ 3.82, p < .001, t(98) ¼ -2.80, p < .01). However, postestimation model checks and sensitivity analyses that excluded cases
with particularly high salivary analyte concentrations (>4 SD from the
mean) revealed that non-linear model estimation of salivary total IgG’s
associations with each of these analytes was especially sensitive to and
inﬂuenced by cases with high analyte concentrations making non-linear
slope estimates tenuous.
There were no signiﬁcant associations between serum total IgG and
the oral immune markers (Table 3), nor between salivary total IgG and
serum MMP-8 nor serum proinﬂammatory cytokines (partial correlations
controlling for salivary total protein: rs ¼ 0.17-0.01, ps > 0.05).

2.6. Analytic steps
Nine salivary MMP-8 determinations tested higher than the assay
upper limit and were replaced with the limit. Six salivary and two serum
MMP-8 determinations were excluded due to high intra-assay CVs. Five
serum total IgG determinations were missing due to sample quality or
type. Most analyte data were positively skewed and kurtotic. Descriptive
analyses examined raw analyte data, and we used log-transformed data
in statistical analyses that assumed normality. There was 5% missing
data for self-reported oral health measures.
We compared levels of total IgG in serum and saliva using a paired
samples t-test and examined the IgG serum-saliva association using a
partial correlation controlling for total protein. To assess the impact of
blood leakage into the oral compartment on these relations, we compared
levels of salivary total IgG in participants with typical (n ¼ 58) vs.
elevated salivary transferrin (n ¼ 41; transferrin threshold ¼ 0.5 mg/dL
(Schwartz and Granger, 2004)) using an independent samples t-test, and
we assessed the serum-saliva correlation for total IgG (adjusted for total
protein) within these subgroups.
The nature, strength, and speciﬁcity of relations between total IgG in
serum and saliva and other oral and systemic immune markers were
assessed using partial correlations (controlling for total protein). We
examined the linearity of these relations using linear regression models
with quadratic slope terms and likelihood ratio tests to compare linear
and quadratic models.
Separate multivariable linear regression models assessed whether
variation in salivary and serum total IgG, and the other oral immune
markers, is related to self-reported oral health measures. Given that few
participants reported brushing less than twice per day (n ¼ 7), oral health
problems (n¼9), and poor/fair access to care (n ¼ 6), differences in
biomeasure concentrations related to these self-reported indices were not

3.3. Total IgG and self-reported oral health
Participants who reported red/pink saliva when brushing their teeth
had higher concentrations of salivary total IgG (M(SD) ¼ 22.96 μg/ml
(19.48)) than those reporting no discoloration (M(SD) ¼ 13.05 μg/mL
(14.18); t(94) ¼ 2.67, p < .01). Salivary total IgG was also associated with
the self-reported oral health composite score with higher salivary total
IgG associated with worse self-reported oral health (t(93) ¼ -2.50, p <
.05). Salivary total IgG was not signiﬁcantly related to ﬂossing frequency.
Similarly, salivary transferrin and MMP-8 were higher among participants reporting red/pink saliva when brushing their teeth (t(94) ¼
3.30, p < .01; t(89) ¼ 2.12, p < .05, respectively), and salivary
3
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Table 2
Descriptive statistics for biomeasuresa.

Saliva
Total IgG (μg/mL)
Total protein (mg/mL)
Transferrin (mg/dL)
MMP-8 (pg/mL)
IL-1β (pg/mL)
IL-6 (pg/mL)
IL-8 (pg/mL)
TNFα (pg/mL)
Serum
Total IgG (μg/mL)
MMP-8 (pg/mL)
IL-1β (pg/mL)
IL-6 (pg/mL)
IL-8 (pg/mL)
TNFα (pg/mL)
a

Mean

Median

SD

Minimum

Maximum

N

15.67
700.76
0.72
76,091.12
264.04
10.09
935.77
5.13

9.92
624.14
0.38
57,082.00
212.60
4.07
681.84
2.54

16.22
364.08
0.85
56,001.50
255.85
16.72
714.76
11.95

0.40
148.53
0.04
5,380.34
9.10
0.35
109.11
0.16

92.60
1,911.19
4.69
20,0000.00
1,591.19
120.93
3,374.14
110.67

99.00
99.00
99.00
93.00
99.00
99.00
99.00
99.00

10,158.69
29,069.52
1.20
1.25
15.43
4.77

9,722.63
18,859.52
1.00
0.58
7.88
2.46

2,987.00
33,156.29
0.77
2.45
33.29
12.55

5,510.00
2,779.13
0.28
0.17
2.26
0.93

23,564.75
17,0277.40
6.23
18.90
246.20
111.72

94.00
97.00
99.00
99.00
99.00
99.00

Raw data are presented. SD¼Standard deviation; MMP-8 ¼ matrix metallopeptidase-8; IL ¼ interleukin; TNFα ¼ tumor necrosis factor-alpha.

(Brandtzaeg, 2007, 2013). It is important to note, however, that gingival
tissues contain IgG-secreting B lymphocytes and plasma cells (Mahanonda et al., 2016; Ebersole, 2003; Kilian et al., 1989), and it is estimated
that up to 20% of IgG concentrations in crevicular ﬂuid may represent
local IgG production (Challacombe et al., 2015). While the origins of total
IgG in our samples of whole saliva cannot be completely delineated, our
ﬁndings suggest coordinated immune function in the oral cavity
involving inﬂammatory, tissue remodeling, and IgG antibody processes.
Taken together, our ﬁndings raise the possibility that salivary total IgG
may serve as an index of the oral immune environment among individuals with varying degrees of oral health.
As noted previously, IgG is a central component of oral mucosa immunity protecting the body from infection and disease. IgG levels increase during both the primary response and the more intense secondary
response when B-cells are exposed to antigens (viruses, toxins, bacteria,
and fungi) (Doan et al., 2008). Many soluble signals involved in initiating
and maintaining the immune response are produced, but the levels of
most of these signals decline rapidly after exposure. By contrast, IgG
levels remain elevated for an extended period after antigen exposure
(Doan et al., 2008). The protracted elevation of IgG post-exposure,
combined with our understanding that the immune system in the oral
compartment is subject to high rates of antigen exposures (Dewhirst
et al., 2010), underscores the potential utility of salivary total IgG as a
surrogate biomarker of the general state of oral immunity (in contrast to
more speciﬁc markers such as cytokines).
We also found signiﬁcant non-linear relations between salivary total
IgG and many other oral immune markers. All non-linear relations were
characterized by steeper, positive slopes at lower analyte concentrations
and a plateauing of slopes at higher analyte concentrations. These nonlinear relations may suggest a potential saturation point at which the
physiological relationship between analytes begins to break down. These
ﬁndings both support the notion that relations between salivary analytes
vary by the nature of the oral immune environment, and underscore the
need for appropriate estimation of salivary analyte relations. Non-linear
associations may be misspeciﬁed or overlooked with traditional linear
modeling. These results also highlight the need for additional studies
examining oral immune processes among healthy, at-risk, and clinical
populations. It is unclear if our non-linear ﬁndings reﬂect the true nature
of the physiologic processes, or if they are driven by extreme data points.
All non-linear relations observed in our study were sensitive to cases with
high salivary analyte concentrations, and our sample did not have
enough participants with higher analyte concentrations to reliably estimate non-linear slopes. Given our healthy and relatively homogenous
sample, additional research is needed to conﬁrm and extend our ﬁndings
in samples reporting both systemic and oral health problems. Future
studies should also explore measurement and modeling approaches for

Table 3
Associations between total IgG in saliva and serum and salivary oral immune
markers.
Salivary Analytes

Transferrin
MMP-8
IL-1β
IL-6
IL-8
TNFα
Oral inﬂammation composite

Salivary total IgG

Serum total IgG

Pearson’s r

Pearson’s r

.77**x
.64**
.57**x
.66**x
.70**x
.55**x
.73**

.06
.05
.02
-.08
-.05
-.14
-.07

*p < .05; **p < .001 (Bonferroni-corrected α¼.007). All analyte data, except
salivary MMP-8 are log-transformed. x indicates signiﬁcant non-linear relations.
Associations are adjusted for ﬂow rate using salivary total protein. MMP-8 ¼
matrix metallopeptidase-8; IL ¼ interleukin; TNFα ¼ tumor necrosis factor-alpha.
Ns ¼ 99 for saliva-saliva and 94 for saliva-serum correlations, except for MMP-8
(Nsaliva-saliva ¼ 93, Nsaliva-serum ¼ 88).

transferrin, MMP-8, and TNFα were inversely associated with the selfreported oral health composite score (t(93) ¼ -2.31, p < .05; t(88) ¼
-2.01, p < .05; t(93) ¼ -2.25, p < .05, respectively). However, the association between salivary TNFα and the oral health composite score was
no longer signiﬁcant when one participant with particularly high salivary
TNFα (110.67 pg/mL) was excluded. All other relations between the oral
immune markers and self-reported oral health measures were not statistically signiﬁcant. There were no signiﬁcant associations between
serum total IgG concentrations and the self-reported oral health
measures.
4. Discussion
Our ﬁndings support the notion that salivary total IgG may serve as a
surrogate index of the oral immune environment when it is not possible
to obtain clinical assessments of oral health and inﬂammation. Salivary
total IgG was positively associated with all the oral immune markers
examined and increased among participants reporting worse oral health.
Salivary total IgG variability was also speciﬁc to the oral compartment
and not related to systemic total IgG nor markers of systemic inﬂammation. Importantly, serum and salivary total IgG levels were not
signiﬁcantly correlated even among participants with higher levels of
blood in their saliva. While other studies have shown the independence
of serum and salivary IgG in both heathy and diseased samples (Challacombe et al., 1995; Patidar et al., 2011; Kandasamy et al., 2016), this
ﬁnding is especially salient given that IgG in saliva is primarily
serum-derived, entering the oral compartment via the gingival crevice

4
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Additional research examining a broader range of biologic and
behavioral factors associated with oral immunity and health is also
needed. Our sample of healthy young adults had too few participants
endorsing smoking and recent medication use to examine the effects of
these behaviors, and we did not have information about other important
biologic factors and health behaviors, such as measures of antiinﬂammatory cytokine activity, bacterial/viral load, oxidative stress,
and eating behaviors (Taba et al., 2005; Salminen et al., 2014; Ghallab,
2018). The relative importance of these factors as confounders in salivary
bioscience studies may vary by sample characteristics (e.g., age, health)
and analyte of interest. To maximize their impact, future studies should
be analyte-speciﬁc and focus on delineating signiﬁcant oral immune and
health confounds for individual salivary biomeasures.
Finally, it is important to recognize that the conceptualization and
measurement of oral health has been studied extensively in ﬁelds such as
oral biology, periodontology, and oral public health using both biologic
and self-report tools (World Health Organization, 2013; U.S. Department
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5. Conclusions
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